CD86 and chronic kidney disease: In contrast, the expression of the M1 signature genes CD32, CD86 and IL-1β (Fig. 4C), as well as IL-6 and iNOS (Supplementary Fig. 3) was significantly increased within ischemic lesions of CKD mice compared to SHAM-operated mice 24 hours after tMCAO.